QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy

Literals

ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035984811&origin=inward
ou:bibtex
- @article { dorado2002,title = {QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy},journal = {European Journal of Clinical Pharmacology},year = {2002},volume = {58},number = {3},pages = {223-224},author = {LLerena, A. and Berecz, R. and De La Rubia, A. and Dorado, P.}}
ou:vecesCitado
- 14
ou:eid
- 2-s2.0-0035984811
dcterms:creator
- LLerena A.
dcterms:contributor
- LLerena, A.; Berecz, R.; De La Rubia, A.; Dorado, P.
bibo:doi
- 10.1007/s00228-002-0452-7
fabio:hasPublicationYear
- 2002
vivo:identifier
- 2002-270
bibo:issn
- 0031-6970
bibo:page_range
- 223-224
dcterms:publisher
- European Journal of Clinical Pharmacology
ou:tipoPublicacion
- Letter
dcterms:title
- QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035984811&origin=inward
ou:urlOrcid
- http://www.scopus.com/inward/record.url?eid=2-s2.0-0035984811&partnerID=MN8TOARS
bibo:volume
- 58